Glaucoma pressure fight: new device vs laser – which wins?
NCT ID NCT02928289
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new device (VISCO™360) against a standard laser treatment to lower eye pressure in adults with open-angle glaucoma. Only 29 people took part before the study was stopped early. The goal was to see which method works better and is safer for controlling the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN-ANGLE GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Coastal Vision Medical Group
Orange, California, 92868, United States
-
Dean McGee Eye Institute
Oklahoma City, Oklahoma, 73104, United States
-
El Paso Eye Surgeons
El Paso, Texas, 79902, United States
-
Ophthalmology Associates
Fort Worth, Texas, 76102, United States
-
Vold Vision
Fayetteville, Arkansas, 72704, United States
-
Wills Eye Hospital
Philadelphia, Pennsylvania, 19107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new eye test match the gold standard for glaucoma?
- Which laser best tames glaucoma pressure?
- Could a single eye implant replace years of glaucoma drops?
- Eye implant could offer long-term pressure control for glaucoma patients
- Glaucoma implant MINIject put to the test in everyday eye clinics
- Glaucoma implant could replace daily eye drops